All filters
Slidesets
Con Standpoint of the Debate - Viet (Mason) Trinh, B.S.
Presented at:
Asia-Pacific HIV Prevention Meeting 2022
Videos
Con Standpoint of the Debate - Viet (Mason) Trinh, B.S.
Presented at:
Asia-Pacific HIV Prevention Meeting 2022
Videos
Con Standpoint of the Debate - Stephane Wen-Wei Ku, MD
Presented at:
Asia-Pacific HIV Prevention Meeting 2022
Videos
Pro Standpoint of the Debate - Udom Likhitwonnawut
Presented at:
Asia-Pacific HIV Prevention Meeting 2022
Videos
Pro Standpoint of the Debate | Jakkrapatara Boonruang, MD
Presented at:
Asia-Pacific HIV Prevention Meeting 2022
Videos
Update on HIV Vaccine and Monoclonal Antibody | Glenda E. Gray, MBBCH, FCPaeds (SA), DSc
Presented at:
Asia-Pacific HIV Prevention Meeting 2022
Videos
Long-Acting PrEP in Low- And Middle-Income Countries - Robin Schaefer, BA, MPH, PhD
Presented at:
Asia-Pacific HIV Prevention Meeting 2022
Videos
PEP in the Era of PrEP - Julie Fox, MBChB. BSc. MRCP. MD
Presented at:
Asia-Pacific HIV Prevention Meeting 2022
Slidesets
CON Perspective - Debate: When Available, Long-Acting Cabotegravir Should be the First Option for PrEP in Public Health Setting - Viet (Mason) Trinh
Presented at:
Asia-Pacific HIV Prevention Meeting 2022
Slidesets
Update on HIV Vaccine and Monoclonal Antibody
Presented at:
Asia-Pacific HIV Prevention Meeting 2022
Slidesets
Long-Acting PrEP in Low- And Middle-Income Countries
Presented at:
Asia-Pacific HIV Prevention Meeting 2022